Tumor-derived RANKL promotes bone loss and skeletal muscle atrophy in a cachexia mouse model of ovarian cancer.108 In addition to peripheral bone destruction, the bone marrow microenvironment may also suffer dysfunction in cancer cachexia. The gene discussed is TNFSF11; the disease is cancer.